Crispina Calsada - 18 Jan 2024 Form 4 Insider Report for Regulus Therapeutics Inc. (RGLS)

Signature
Christopher Aker, Attorney in Fact
Issuer symbol
RGLS
Transactions as of
18 Jan 2024
Net transactions value
-$6,510
Form type
4
Filing time
18 Jan 2024, 20:24:29 UTC
Previous filing
17 Jan 2024
Next filing
21 May 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RGLS Common Stock Sale $6,510 -5,468 -49% $1.19 5,782 18 Jan 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares of common stock to cover tax withholding obligations incurred in connection with the vesting of the restricted stock unit award received by the Reporting Person on 1/11/2023.